The protective effect of anti-IL-22 is blunted in IFN-γ deficient mice, indicating that increased IFN-γ responses associated with the administration of anti-IL-22 plays a dominant role behind its protective function during arthritis. Here, IL22 is linked to arthritic joint disease.